Investigational regenerative protocol for psoriasis using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.
Clinical Rationale
Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete paracrine factors that may help regulate aberrant T-cell activity and reduce pro-inflammatory cytokines involved in psoriatic inflammation. The protocol is strictly adjunctive; conventional dermatologic care remains mandatory. Physical therapy addresses joint stiffness and mobility; nutritional medicine focuses on anti‑inflammatory patterns. All techniques are minimally invasive (intradermal or subcutaneous microinjections). Peer‑reviewed investigations focus on safety and preliminary efficacy.